National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

IMMU-106

 A monoclonal antibody that is being studied in the treatment of refractory B-cell non-Hodgkin lymphoma. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. IMMU-106 binds to the protein CD20, which is found on B cells (a type of immune system cell), and some types of lymphoma cells. Also called hA20 and HCD20.



Previous Definitions:imatinib mesylate, imexon, imipenem, imiquimod, immature teratoma
Next Definitions:immune adjuvant, immune complex hemolytic anemia, immune function, immune response, immune system

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov